A pediatric patient who is being treated for community-acquired pneumonia (CAP) and parapneumonic effusion should be monitored for response to therapy. Therapy may need to be changed based on the clinical findings. The authors are from the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.